High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world setting

BACKGROUND: Patients with hepatitis C virus (HCV) genotype 3 infection remain a difficult-to-cure population. This study evaluated the efficacy and safety of sofosbuvir-based regimen in genotype 3 patients in a real-world setting. METHODS: HCV genotype 3a-infected adults with compensated liver disea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Virol J
Autors principals: Han, Qunying, Fan, Xiude, Wang, Xiaoyun, Wang, Ye, Deng, Huan, Zhang, Xiaoge, Zhang, Kun, Li, Na, Liu, Zhengwen
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6547524/
https://ncbi.nlm.nih.gov/pubmed/31159813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-019-1184-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars